• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68岁患有难治性皮肤型皮肌炎的女性。

68-year old woman with refractory cutaneous dermatomyositis.

作者信息

Antonopoulos Ioannis, Liossis Stamatis-Nick

机构信息

Patras University Hospital, Department of Internal Medicine, Division of Rheumatology, Rion, Patras, Greece.

Univerity of Patras Medical School, Rion, Patras, Greece.

出版信息

Mediterr J Rheumatol. 2018 Dec 18;29(4):221-223. doi: 10.31138/mjr.29.4.221. eCollection 2018 Dec.

DOI:10.31138/mjr.29.4.221
PMID:32185331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7045944/
Abstract

Dermatomyositis is an idiopathic inflammatory disorder of the muscles associated with characteristic cutaneous findings. Herein we report a 68-year old woman who presented with dermatomyositis associated with painful vasculitic lesions on both hands, refractory to conventional treatment. Steroids, topical tacrolimus, antimalarials and intravenous cyclophosphamide were tried with no beneficial effect. Rituximab was also administered with no initial effect; soon afterwards, intravenous immunoglobulin was administered with good results. Some cases of cutaneous dermatomyositis may require trials of different therapies to identify the treatment regimen that produces satisfactory disease control.

摘要

皮肌炎是一种与特征性皮肤表现相关的特发性肌肉炎性疾病。在此,我们报告一名68岁女性,她患有皮肌炎,双手出现疼痛性血管炎性病变,对传统治疗无效。曾尝试使用类固醇、外用他克莫司、抗疟药和静脉注射环磷酰胺,但均无有益效果。使用利妥昔单抗也未见初始疗效;此后不久,静脉注射免疫球蛋白取得了良好效果。一些皮肤型皮肌炎病例可能需要尝试不同的治疗方法,以确定能实现满意疾病控制的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/7045944/6641375c975b/MJR-29-4-221-g001b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/7045944/93aaa3031a5f/MJR-29-4-221-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/7045944/6641375c975b/MJR-29-4-221-g001b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/7045944/93aaa3031a5f/MJR-29-4-221-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/7045944/6641375c975b/MJR-29-4-221-g001b.jpg

相似文献

1
68-year old woman with refractory cutaneous dermatomyositis.68岁患有难治性皮肤型皮肌炎的女性。
Mediterr J Rheumatol. 2018 Dec 18;29(4):221-223. doi: 10.31138/mjr.29.4.221. eCollection 2018 Dec.
2
Management of cutaneous dermatomyositis: current therapeutic options.皮肤型皮肌炎的管理:当前的治疗选择
Am J Clin Dermatol. 2006;7(6):341-51. doi: 10.2165/00128071-200607060-00002.
3
Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study.
J Dermatolog Treat. 2004 Jan;15(1):35-9. doi: 10.1080/09546630310018509.
4
Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy.静脉注射环磷酰胺脉冲疗法使伴难治性皮肤血管炎的皮肌炎完全缓解。
Intern Med. 2008;47(21):1935-40. doi: 10.2169/internalmedicine.47.1289. Epub 2008 Nov 4.
5
[Topical tacrolimus and resistant skin lesions of dermatomyositis].
Rev Med Interne. 2006 Oct;27(10):730-5. doi: 10.1016/j.revmed.2006.06.015. Epub 2006 Jul 26.
6
Successful Treatment of Refractory Cutaneous Manifestations of Dermatomyositis With Intravenous Immunoglobulin: A Case Report.静脉注射免疫球蛋白成功治疗皮肌炎难治性皮肤表现:一例报告
Cureus. 2024 Sep 3;16(9):e68518. doi: 10.7759/cureus.68518. eCollection 2024 Sep.
7
Cutaneous dermatomyositis in the era of biologicals.生物制剂时代的皮肤型皮肌炎
Semin Immunopathol. 2016 Jan;38(1):113-21. doi: 10.1007/s00281-015-0543-z. Epub 2015 Nov 12.
8
Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.外用FK506(他克莫司)治疗皮肤型红斑狼疮和皮肌炎的面部红斑性皮损
Eur J Dermatol. 2002 Jan-Feb;12(1):50-2.
9
Unilateral Eyelid Swelling as a Sign of Antimelanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Antibody-Positive Dermatomyositis.单侧眼睑肿胀作为抗黑色素瘤分化相关基因5(抗MDA5)抗体阳性皮肌炎的体征
Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):e209-e211. doi: 10.1097/IOP.0000000000001258.
10
Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.静脉注射免疫球蛋白治疗青少年皮肌炎——9例患者的4年回顾
Arch Dis Child. 1995 Jan;72(1):25-8. doi: 10.1136/adc.72.1.25.

引用本文的文献

1
Mediterranean Journal of Rheumatology December 2018 Highlights.《地中海风湿病学杂志》2018年12月亮点
Mediterr J Rheumatol. 2018 Dec 18;29(4):182-183. doi: 10.31138/mjr.29.4.182. eCollection 2018 Dec.

本文引用的文献

1
The effect of intravenous immunoglobulin (IVIG) treatment on patients with dermatomyositis: a 4-year follow-up study.静脉注射免疫球蛋白(IVIG)治疗皮肌炎患者的效果:一项为期 4 年的随访研究。
Clin Exp Rheumatol. 2012 May-Jun;30(3):397-401. Epub 2012 Jun 26.
2
Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.利妥昔单抗治疗儿童皮肌炎:4例儿科患者的报告
Arthritis Rheum. 2007 Sep;56(9):3107-11. doi: 10.1002/art.22856.
3
Treatment of refractory polymyositis and dermatomyositis.难治性多发性肌炎和皮肌炎的治疗。
Curr Rheumatol Rep. 2006 Jun;8(3):167-73. doi: 10.1007/s11926-996-0021-7.
4
Mycophenolate mofetil in dermatomyositis: is it safe?霉酚酸酯治疗皮肌炎:安全吗?
Neurology. 2006 Apr 25;66(8):1245-7. doi: 10.1212/01.wnl.0000208416.32471.c0.
5
Rituximab in the treatment of dermatomyositis: an open-label pilot study.利妥昔单抗治疗皮肌炎:一项开放标签的试点研究。
Arthritis Rheum. 2005 Feb;52(2):601-7. doi: 10.1002/art.20849.
6
Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy.霉酚酸酯(骁悉):自身免疫性炎性肌病的一种替代疗法。
Rheumatology (Oxford). 2005 Mar;44(3):386-9. doi: 10.1093/rheumatology/keh499. Epub 2004 Nov 30.
7
Mycophenolate mofetil for dermatomyositis.霉酚酸酯治疗皮肌炎。
Dermatology. 2001;202(4):341-3. doi: 10.1159/000051674.
8
Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin.大剂量静脉注射免疫球蛋白治疗后炎性肌病患者肌肉中转化生长因子-β1 mRNA和蛋白的下调
Clin Immunol. 2000 Feb;94(2):99-104. doi: 10.1006/clim.1999.4823.
9
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.大剂量静脉注射免疫球蛋白输注治疗皮肌炎的对照试验。
N Engl J Med. 1993 Dec 30;329(27):1993-2000. doi: 10.1056/NEJM199312303292704.
10
High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.大剂量静脉注射免疫球蛋白通过阻断活化补体片段在肌内膜的沉积,对皮肌炎患者发挥有益作用。
J Clin Invest. 1994 Nov;94(5):1729-35. doi: 10.1172/JCI117520.